Shares Bazaar

Marksans Pharma Ltd.   (BSE: MARKSANS)

NSE   0.00  
OPEN PRICE(₹)
0.00
HIGH PRICE(₹)
0.00
LOW PRICE(₹)
0.00
CLOSE PRICE(₹)
0.00
VOLUME
0.00
52 WK LOW (₹)
34.35 (27-07-2020)
52 WK HIGH (₹)
97.6 (14-06-2021)
BSE   49.3  
OPEN PRICE₹)
50.3
HIGH PRICE(₹)
50.3
LOW PRICE (₹)
49.15
CLOSE PRICE(₹)
49.3
VOLUME
80432
VALUE
3965300
BID QTY
0
OFFER QTY
0

Stock Summary

Trade Value (₹ in Lacs) : 409.31 MCap (₹ in Mn) : 22716.91 Dividend Yield(%) : 0.18 Price/Earning (TTM) : 34.43
TTM EPS (₹) : 0 Price/Sales (TTM) : 0 P/E Ratio : 0.01 Price/Book (MRQ) : 4.15
Book Value(₹) : 0 Face Value(₹) : 0 Latest Reserve (₹ in Mn): 5062.85 EPSc : 0.93
PE : 59.94 TTMNP : 659.78 TTMTAX : 192.48 TTMINTEREST : 50.45
TTMDEPRECIATION : 133.59 TTMNetSales : 5240.26 EV_Sales : 4.33 EV (in Mn) : 22683.85
TTMEBITDA : 1036.3 EV_EBITDA : 21.89 TTMCashProfit : 793.37 TTMCEPS : 1.94
Price_CEPS : 28.63 TTMNPAEX : 659.78

Peer Group Compare

Comp. Name Price M.Cap Div Yld % P/E Ratio Price/Earning (TTM) TTM EPS (₹)
Sun Pharmaceutical Industries Ltd. (BSE)

920.8 ( 1.53%)

135418.47 0.71 0 47 12.01
Divis Laboratories Ltd. (BSE)

3641.9 ( 1.71%)

91003.96 0.47 0.06 51.76 66.23
Dr. Reddys Laboratories Ltd. (BSE)

4139.5 ( -1.04%)

81092.78 0.51 0.04 33.02 147.67
Cipla Ltd. (BSE)

1067.8 ( 0.57%)

67867.68 0.48 0.01 30.26 27.81
Aurobindo Pharma Ltd. (BSE)

517.45 ( -0.59%)

55333.11 0.32 0.01 20.8 45.4

Management Info

Chairman : Mark Saldanha
Managing Director : Mark Saldanha
Company Secretory : Harshavardhan Panigrahi
Incorporation Year : 1992

Registered Office

Address : 11th Floor, " Grandeur "
Opp. Gundeecha Symphony, Veera Desai Extension Road
Oshiwara, Andheri (W)
City-Pincode : Mumbai-400053
Phone : 022- 40012000
Website : www.marksanspharma.com
Email : companysecretary@marksanspharma.com

Registrars Details

Registrars Details : Bigshare Services Pvt Ltd
Address : Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: +91 21 62638299(Old Address) E-2&3 , Ansa Industrial Estate,Saki Vihar Road,Saki Naka, Andheri (E),Mumbai
Listing : BSE, NSE

Balance Sheet

(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
SOURCES OF FUNDS:
Share Capital 409313.7 409313.7 409313.7 409313.7 534313.7
  Equity - Authorised 550000 550000 550000 550000 550000
  Equity - Issued 409313.7 409313.7 409313.7 409313.7 409313.7
 Equity Paid Up 409313.7 409313.7 409313.7 409313.7 409313.7
  Equity Shares Forfeited 0.00 0.00 0.00 0.00 0.00
  Adjustments to Equity 0.00 0.00 0.00 0.00 0.00
  Preference Capital Paid Up 0.00 0 0.00 0 125000
  Face Value 0 0 0 0 0
Share Warrants & Outstandings 0.00 0.00 0.00 0.00 0.00
Total Reserves 5950828.84 5015509.49 4299332.36 3925010.98 4008931.09
  Securities Premium 1751317.33 1751317.33 1751317.33 1751317.33 1751317.33
  Capital Reserves 122.5 122.5 122.5 122.5 122.5
  Profit & Loss Account Balances 851091.43 29783.56 -690701.84 -986694.34 -920084.88
  General Reserves 3137365.57 3137365.57 3137365.57 3137365.57 3137365.57
Reserve excluding Revaluation Reserve 5950828.84 5015509.49 4299332.36 3925010.98 4008931.09
Revaluation Reserves 0.00 0 0.00 0 0.00
Deposits 0.00 0.00 0.00 0.00 0.00
  Demand Deposits 0.00 0.00 0.00 0.00 0.00
  Savings Deposit 0.00 0.00 0.00 0.00 0.00
  Term Deposits / Fixed Deposits 0.00 0.00 0.00 0.00 0.00
  Current Deposits 0.00 0.00 0.00 0.00 0.00
  Recurring Deposits 0.00 0.00 0.00 0.00 0.00
  Other Deposits 0.00 0.00 0.00 0.00 0.00
Borrowings 0.00 0.00 0.00 0.00 0.00
  Borrowings From Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Banks 0.00 0.00 0.00 0.00 0.00
  Borrowings From GOI 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Financial Institutions 0.00 0.00 0.00 0.00 0.00
  Borrowings in the form of Bonds / Debentures 0.00 0.00 0.00 0.00 0.00
  Borrowings in Other Form 0.00 0.00 0.00 0.00 0.00
Other Liabilities & Provisions 0.00 0.00 0.00 0.00 0.00
  Bills Payable 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Liabilities 0.00 0.00 0.00 0.00 0.00
  Interest Accrued 0.00 0.00 0.00 0.00 0.00
  Proposed Dividend 0.00 0.00 0.00 0.00 0.00
  Corporate dividend tax payable 0.00 0.00 0.00 0.00 0.00
  Other Liabilities & Provisions 14745.76 13557.4 10804.34 9608.78 0.00
Total Liabilities 6663605.08 5640548.98 4914944.53 4516407.19 4626850.9
APPLICATION OF FUNDS :
Cash and balance with Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Cash with RBI 0.00 0.00 0.00 0.00 0.00
  Cash in hand & others 0.00 0.00 0.00 0.00 0.00
Balances with banks and money at call 0.00 0.00 0.00 0.00 0.00
Investments 33024.48 12919.96 8166.03 5880.9 104061.74
Investments in India 0.00 0.00 0.00 0.00 0.00
  GOI/State Govt. Securities 0.00 0.00 0.00 0.00 0.00
  Equity Shares - Corporate 0.00 0.00 0.00 0.00 0.00
  Debentures & Bonds 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures/Associates 0.00 0.00 0.00 0.00 0.00
  Units - MF/ Insurance/CP/PTC 0.00 0.00 0.00 0.00 0.00
Investments outside India 0.00 0.00 0.00 0.00 0.00
  Government securitiesC 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures abroad 0.00 0.00 0.00 0.00 0.00
  Other investments outside India 0.00 0.00 0.00 0.00 0.00
  Less: Prov for Diminution in Value of Invest. 0.00 0.00 0.00 0.00 0.00
Advances 0.00 0.00 0.00 0.00 0.00
  Bills Purchased & Discounted 0.00 0.00 0.00 0.00 0.00
  Cash Credit, Over Draft & Loans repayable 0.00 0.00 0.00 0.00 0.00
  Term Loans 0.00 0.00 0.00 0.00 0.00
  Finance lease and hire purchase receivable 0.00 0.00 0.00 0.00 0.00
Gross block 5653894.62 5062638.18 4953473.92 4564912.06 4294731.62
  Premises 1259420.27 1227856.02 1214877.95 966597.38 891333.86
  Assets Given on Lease 0.00 0.00 0.00 0.00 0.00
  Other Fixed Assets 120878.45 0.00 0.00 0.00 0.00
Less: Accumulated Depreciation 2626733.15 2365375.59 2159699.04 1895159.28 1598186.47
Net Block 3027161.47 2697262.59 2793774.88 2669752.78 2696545.15
Less: Impairment of Assets 0.00 0.00 0.00 0.00 0.00
Lease Adjustment 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 0 0 0 3598.46 0
Other Assets 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Assets 0.00 0.00 0.00 0.00 0.00
  Interest Accrued Assets 0.00 0.00 0.00 0.00 0.00
  Tax paid in advance/TDS 0.00 0.00 0.00 0.00 0.00
  Stationery and stamps 0.00 0.00 0.00 0.00 0.00
  Non-banking assets acquired 0.00 0.00 0.00 0.00 0.00
  Deferred tax asset 0.00 0.00 0.00 0.00 0.00
  Miscellaneous Expenditure not written off 0.00 0.00 0.00 0.00 0.00
Total Assets 6663605.08 5640548.98 4914944.53 4516407.19 4626850.9
Contingent Liabilities 481697.61 304012.75 110467.72 92047 97134
  Claims not acknowledged as debts 5799.49 5799.49 5799.49 0.00 3197
  Outstanding forward exchange contracts 0.00 0.00 0.00 0.00 0.00
  Guarantees given in India 0.00 0.00 0.00 0.00 0.00
  Guarantees given Outside India 0.00 0.00 0.00 0.00 0.00
  Acceptances, endorsements & other obligations 0.00 0.00 0.00 0.00 0.00
Bills for collection 0.00 0.00 0.00 0.00 0.00
Book Value 0.02 0.01 0.01 0.01 0.01
Adjusted Book Value 0.02 0.01 0.01 0.01 0.01
(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
SOURCES OF FUNDS:
Share Capital 100000 100000 100000 100000 100000
  Equity - Authorised 550000 550000 550000 550000 550000
  Equity - Issued 100000 100000 100000 100000 100000
 Equity Paid Up 100000 100000 100000 100000 100000
  Equity Shares Forfeited 0.00 0.00 0.00 0.00 0.00
  Adjustments to Equity 0.00 0.00 0.00 0.00 0.00
  Preference Capital Paid Up 0.00 0.00 0.00 0.00 125000
  Face Value 0 0 0 0 0
Share Warrants & Outstandings 0.00 0.00 0.00 0.00 0.00
Total Reserves 100000 100000 100000 100000 100000
  Securities Premium 100000 100000 100000 100000 100000
  Capital Reserves 122.5 122.5 122.5 122.5 122.5
  Profit & Loss Account Balances -100000 -100000 -100000 -100000 -100000
  General Reserves 100000 100000 100000 100000 100000
Reserve excluding Revaluation Reserve 100000 100000 100000 100000 100000
Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
Deposits 0.00 0.00 0.00 0.00 0.00
  Demand Deposits 0.00 0.00 0.00 0.00 0.00
  Savings Deposit 0.00 0.00 0.00 0.00 0.00
  Term Deposits / Fixed Deposits 0.00 0.00 0.00 0.00 0.00
  Current Deposits 0.00 0.00 0.00 0.00 0.00
  Recurring Deposits 0.00 0.00 0.00 0.00 0.00
  Other Deposits 0.00 0.00 0.00 0.00 0.00
Borrowings 0.00 0.00 0.00 0.00 0.00
  Borrowings From Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Banks 0.00 0.00 0.00 0.00 0.00
  Borrowings From GOI 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Financial Institutions 0.00 0.00 0.00 0.00 0.00
  Borrowings in the form of Bonds / Debentures 0.00 0.00 0.00 0.00 0.00
  Borrowings in Other Form 0.00 0.00 0.00 0.00 0.00
Other Liabilities & Provisions 0.00 0.00 0.00 0.00 0.00
  Bills Payable 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Liabilities 0.00 0.00 0.00 0.00 0.00
  Interest Accrued 0.00 0.00 0.00 0.00 0.00
  Proposed Dividend 0.00 0.00 0.00 0.00 0.00
  Corporate dividend tax payable 0.00 0.00 0.00 0.00 0.00
  Other Liabilities & Provisions 14745.76 13557.4 10804.34 9608.78 0
Total Liabilities 100000 100000 100000 100000 100000
APPLICATION OF FUNDS :
Cash and balance with Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Cash with RBI 0.00 0.00 0.00 0.00 0.00
  Cash in hand & others 0.00 0.00 0.00 0.00 0.00
Balances with banks and money at call 0.00 0.00 0.00 0.00 0.00
Investments 100000 100000 100000 100000 100000
Investments in India 0.00 0.00 0.00 0.00 0.00
  GOI/State Govt. Securities 0.00 0.00 0.00 0.00 0.00
  Equity Shares - Corporate 0.00 0.00 0.00 0.00 0.00
  Debentures & Bonds 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures/Associates 0.00 0.00 0.00 0.00 0.00
  Units - MF/ Insurance/CP/PTC 0.00 0.00 0.00 0.00 0.00
Investments outside India 0.00 0.00 0.00 0.00 0.00
  Government securitiesC 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures abroad 0.00 0.00 0.00 0.00 0.00
  Other investments outside India 0.00 0.00 0.00 0.00 0.00
  Less: Prov for Diminution in Value of Invest. 0.00 0.00 0.00 0.00 0.00
Advances 0.00 0.00 0.00 0.00 0.00
  Bills Purchased & Discounted 0.00 0.00 0.00 0.00 0.00
  Cash Credit, Over Draft & Loans repayable 0.00 0.00 0.00 0.00 0.00
  Term Loans 0.00 0.00 0.00 0.00 0.00
  Finance lease and hire purchase receivable 0.00 0.00 0.00 0.00 0.00
Gross block 100000 100000 100000 100000 100000
  Premises 100000 100000 100000 100000 100000
  Assets Given on Lease 0.00 0.00 0.00 0.00 0.00
  Other Fixed Assets 120878.45 0.00 0.00 0.00 0.00
Less: Accumulated Depreciation 100000 100000 100000 100000 100000
Net Block 100000 100000 100000 100000 100000
Less: Impairment of Assets 0 0 0 0 0
Lease Adjustment 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 0 0 0 3598.46 0
Other Assets 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Assets 0.00 0.00 0.00 0.00 0.00
  Interest Accrued Assets 0.00 0.00 0.00 0.00 0.00
  Tax paid in advance/TDS 0.00 0.00 0.00 0.00 0.00
  Stationery and stamps 0.00 0.00 0.00 0.00 0.00
  Non-banking assets acquired 0.00 0.00 0.00 0.00 0.00
  Deferred tax asset 0.00 0.00 0.00 0.00 0.00
  Miscellaneous Expenditure not written off 0.00 0.00 0.00 0.00 0.00
Total Assets 100000 100000 100000 100000 100000
Contingent Liabilities 100000 100000 100000 92047 97134
  Claims not acknowledged as debts 5799.49 5799.49 5799.49 0 3197
  Outstanding forward exchange contracts 0.00 0.00 0.00 0.00 0.00
  Guarantees given in India 0.00 0.00 0.00 0.00 0.00
  Guarantees given Outside India 0.00 0.00 0.00 0.00 0.00
  Acceptances, endorsements & other obligations 0.00 0.00 0.00 0.00 0.00
Bills for collection 0.00 0.00 0.00 0.00 0.00
Book Value 0.01 0.01 0.01 0.01 0.01
Adjusted Book Value 0.01 0.01 0.01 0.01 0.01

Quarterly Results

Particulars Sep-2020 Jun-2020 Mar-2020 Feb-2019
Date End Audited Audited Audited Audited
Interest Earned 3564.69 3311.52 3353.49 2876.49
Income On Investments 0.00 0.00 0.00 0.00
Interest On Balances With Rbi Other Inter Bank Funds 0.00 0.00 0.00 0.00
Interest / Discount On Advances / Bills 0 0 0 0
Others 0 0 0 0
Other Income 36.68 1.82 0.26 0.26
Total Income 3601.37 3313.34 3353.75 2876.75
Interest Expended 19.34 15.5 20.35 16.49
Operating Expenses 0 0 0 0
Total Expenditure 2733.13 2611.33 2661.51 2403.62
Operating Profit Before Provisions and Contingencies 868.24 702.01 692.24 473.13
Exceptional Items 0 0 0 0
Provisions and contingencies 0 0 0 0
Profit Before Tax 658.98 614.02 575.63 383.37
Tax 151.64 120.37 148.23 87.75
Profit After Tax 507.34 493.65 427.4 295.62
+/- Extraordinary Items 0 0 0 0
+/- Prior period items 0 0 0 0
Net Profit 507.34 493.65 427.4 295.62
Minority Interest 0 0 0 -3.85
Shares of Associates 0 0 0 0
Other related items 0 0 0 0
Misc. Expenses Written off 0.00 0.00 0.00 0.00
Consolidated Net Profit 507.34 493.65 427.4 295.62
Equity Capital 507.34 493.65 427.4 291.77
Face Value (IN RS) 1 1 1 1
Reserves 0 0 0 0
% of Shares held by Govt 0 0 0 0
Capital Adequacy Ratio 0.00 0.00 0.00 0.00
Gross / Net NPAs 0.00 0.00 0.00 0.00
Amount of Gross NPAs 0.00 0.00 0.00 0.00
Amount of Net NPAs 0 0 0 0
% of Gross / Net NPAs NA NA NA NA
% of Net NPAs 0 0 0 0
% of Gross NPAs 0 0 0 0
Return on Assets 0 0 0 0
No of Public Share Holdings NA NA NA NA
% of Public Share Holdings NA NA NA NA
Basic Eps After Extraordinary Items 1.21 1.2 1 0.71
Basic Eps Before Extraordinary Items 1.21 1.2 1 0.71
PBIDTM% 24.36 21.2 20.64 16.45
PBDTM% 23.81 20.73 20.04 15.87
PBTM% 18.49 18.54 17.17 13.33
PATM% 14.23 14.91 12.74 10.28
Particulars Mar-2020
Date End Audited
Interest Earned 1136.4
Income On Investments 0
Interest On Balances With Rbi Other Inter Bank Funds 0
Interest / Discount On Advances / Bills 0
Others 0.00
Other Income -0.8
Total Income 1135.5
Interest Expended 16.7
Operating Expenses 0.00
Total Expenditure 952.5
Operating Profit Before Provisions and Contingencies 183.1
Exceptional Items 0
Provisions and contingencies 0.00
Profit Before Tax 131.7
Tax 57.6
Profit After Tax 74.1
+/- Extraordinary Items 0.00
+/- Prior period items 0.00
Net Profit 74.1
Minority Interest 0.00
Shares of Associates 0.00
Other related items 0.00
Misc. Expenses Written off 0.00
Consolidated Net Profit 74.1
Equity Capital 74.1
Face Value (IN RS) 1
Reserves 0
% of Shares held by Govt 0.00
Capital Adequacy Ratio 0.00
Gross / Net NPAs 0.00
Amount of Gross NPAs 0.00
Amount of Net NPAs 0.00
% of Gross / Net NPAs NA
% of Net NPAs 0.00
% of Gross NPAs 0.00
Return on Assets 0.00
No of Public Share Holdings NA
% of Public Share Holdings NA
Basic Eps After Extraordinary Items 0.18
Basic Eps Before Extraordinary Items 0.18
PBIDTM% 16.11
PBDTM% 14.64
PBTM% 11.59
PATM% 6.52

Profit-Loss

-
Particulars
-
Particulars

Financial Ratios

Particulars
Particulars

Cash Flow

(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Net Profit Before Taxes 1571717.68 1043065.85 497980.9 148973.69 1068506.77
Adjustments for Expenses & Provisions : 420382.14 318842.27 439851.15 265755.86 396279.12
Adjustments for Liabilities & Assets: 357335.64 -817919.91 -362277.13 -60376.85 -881355.22
Refund/(payment) of direct taxes -250001.01 -270037.75 -74638.26 -213740.72 -275425.79
Other Direct payments 0 0 0 0 0
Cash Flow from operating activities 2099434.45 273950.47 500916.67 140611.97 308004.88
Cash Flow from investing activities -595298.84 -134795.85 -388092.37 -207266.63 -1230117.61
Cash Flow from financing activities -901478.47 -207771.5 33847.93 -34737.26 -577526.02
Effect of exchange fluctuation on translation reserve 0 0 0 0 0
Net increase/(decrease) in cash and cash equivalents 602657.14 -68616.88 146672.22 -101391.91 -1499638.75
Opening Cash & Cash Equivalents 328549.5 397166.39 250494.16 353013.34 1852652.1
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0 0 0 0 0
Closing Cash & Cash Equivalent 931206.65 328549.5 397166.39 251621.43 353013.34
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0 0 0 0 0
(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Net Profit Before Taxes 1571717.68 1043065.85 497980.9 148973.69 1068506.77
Adjustments for Expenses & Provisions : 420382.14 318842.27 439851.15 265755.86 396279.12
Adjustments for Liabilities & Assets: 357335.64 -817919.91 -362277.13 -60376.85 -881355.22
Refund/(payment) of direct taxes -250001.01 -270037.75 -74638.26 -213740.72 -275425.79
Other Direct payments 0 0 0 0 0
Cash Flow from operating activities 2099434.45 273950.47 500916.67 140611.97 308004.88
Cash Flow from investing activities -595298.84 -134795.85 -388092.37 -207266.63 -1230117.61
Cash Flow from financing activities -901478.47 -207771.5 33847.93 -34737.26 -577526.02
Effect of exchange fluctuation on translation reserve 0 0 0 0 0
Net increase/(decrease) in cash and cash equivalents 602657.14 -68616.88 146672.22 -101391.91 -1499638.75
Opening Cash & Cash Equivalents 328549.5 397166.39 250494.16 353013.34 1852652.1
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0 0 0 0 0
Closing Cash & Cash Equivalent 931206.65 328549.5 397166.39 251621.43 353013.34
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0 0 0 0 0

Share Price

Year Open Price (₹) High Price (₹) Low Price (₹) Close Price (₹) Volume (000's) Value (in Lakhs)
February-2021 56.1 64.2 54.55 56.9 2172.95 1288.4
January-2021 61 64.5 53 55 4020.63 2387.76
December-2020 58.5 66.1 48.6 60.6 8819.54 5334.68
November-2020 51.8 62.65 48 58.9 9292.54 5238.84
October-2020 50.5 56 48.4 50.9 5222.38 2740.91
September-2020 45.6 55 43.5 50.3 5188.6 2546.64
August-2020 40.65 57.1 40.1 45.65 10543.75 5209.57
Marksans Pharma soars on getting USFDA approval for Pregabalin Capsules21-Jul-2022 02:24 PM  
Marksans Pharma gets USFDA approval for Pregabalin Capsules21-Jul-2022 02:20 PM  
Marksans Pharma informs about board meeting intimation 04-Jul-2022 05:06 PM  
Marksans Pharma falls after its arm recalls Kroger Brand Aspirin and Ibuprofen bottles22-Jun-2022 11:24 AM  
Marksans Pharma’s arm recalls Kroger Brand Aspirin and Ibuprofen bottles21-Jun-2022 12:48 PM  
Marksans Pharma informs about disclosure10-Jun-2022 02:54 PM  
Marksans Pharma acquires entire stake in Access Healthcare 10-Jun-2022 02:22 PM  
Marksans Pharma informs about newspaper publication01-Jun-2022 01:17 PM  
Marksans Pharma board recommends dividend 31-May-2022 05:01 PM  
Marksans Pharma informs about disclosure25-Apr-2022 04:51 PM  
Marksans Pharma inks pact to acquire 100% stake in Access Healthcare for Medical Products25-Apr-2022 02:24 PM  
Marksans Pharma informs about non- applicability of large corporate entity14-Apr-2022 12:37 PM  
Marksans Pharma’s arm gets UK MHRA nod for Bells Healthcare All in One Oral Solution22-Feb-2022 02:35 PM  
Marksans Pharma zooms on getting USFDA’s approval for Cetirizine Hydrochloride Tablets11-Jan-2022 12:57 PM  
Marksans Pharma gets USFDA’s approval for Cetirizine Hydrochloride Tablets11-Jan-2022 12:37 PM